Document is current
Any future updates will be listed below
-
Authors
Takizawa, Jun https://orcid.org/0009-0000-7125-3927
Yoshida, Isao
Ogawa, Yoshiaki
Toubai, Tomomi
Kusumoto, Shigeru
Watanabe, Mitsumasa
Ogawa, Natsumi
Satomi, Natsuko
Nishimura, Yasuko
Honda, Hideyuki
Chyla, Brenda
Izutsu, Koji
-
Funding
Funding for this research was provided by:
AbbVie G.K.
- License Information
-
More Information
Article History
Received: 20 August 2025
Revised: 13 November 2025
Accepted: 17 November 2025
First Online: 28 November 2025
Declarations
:
: Jun Takizawa: Consultancy (including expert testimony): Janssen, AstraZeneca, AbbVie; Research Funding: AstraZeneca, Mitsubishi Tanabe, AbbVie, BeiGene, Novartis, Chugai, Kyowa Kirin, Nippon Kayaku, Janssen, Eli Lilly, Asahi Kasei; Honoraria: Janssen, AstraZeneca, AbbVie, Novartis, BeiGene, Chugai, Kyowa Kirin, Nippon Kayaku. Isao Yoshida: Honoraria: Chugai, Kyowa Kirin, AstraZeneca, Eisai, Janssen, Daiichi Sankyo, AbbVie, Nippon Shinyaku. Yoshiaki Ogawa: None. Tomomi Toubai: Honoraria: Takeda; Research grants: IQVIA, AbbVie, Meiji Seika Pharma, Novartis, Chugai, Pfizer, Sanofi, Amgen, Incyte, Zenyaku. Shigeru Kusumoto: Consultant/adviser: Lilly, Chugai Pharmaceutical, Kyowa Kirin, Genmab, and Janssen; Honoraria: Chugai Pharmaceutical, Eisai, Janssen, Meiji Seika Pharma, AbbVie, Nippon Shinyaku, Astellas Pharma, Novartis, Zenyaku, Fujimoto Pharmaceutical, Daiichi Sankyo, SymBio Pharmaceuticals, Ono Pharmaceutical, Lilly, Genmab, Sanofi, Takeda Pharmaceuticals, Sumitomo Pharma, Mundipharma, AstraZeneca; Research grants: Bristol Myers Squibb, Chugai Pharmaceutical, Ono Pharmaceutical, Genmab, Meiji Seika Pharma, Janssen, Takeda Pharmaceuticals, AbbVie. Mitsumasa Watanabe: None. Natsumi Ogawa: Stock holdings: AbbVie; Employment: AbbVie. Natsuko Satomi: Stock holdings: AbbVie; Employment: AbbVie. Yasuko Nishimura: Stock holdings: AbbVie; Employment: AbbVie. Hideyuki Honda: Stock holdings: AbbVie; Employment: AbbVie. Brenda Chyla: Stock holdings: AbbVie; Employment: AbbVie. Koji Izutsu: Writing payment: None; Research grants: AstraZeneca, AbbVie, Incyte, Bristol Myers Squibb, Novartis, Yakult, Daiichi Sankyo, Chugai, BeiGene, Genmab, LOXO Oncology, Otsuka, Regeneron.
